Asia Pacific Pharmaceutical Excipients Market Size, Share, and COVID-19 Impact Analysis, By Product (Organic Chemicals, Inorganic Chemicals, and Other Products), By Functionality (Binder, Suspension & Viscosity Agents, Glidants, and Others), and Asia Pacific Pharmaceutical Excipients Market Insights, Industry Trend, Forecasts to 203

Asia Pacific Pharmaceutical Excipients Market Insights Forecasts to 2035

• The Asia Pacific Pharmaceutical Excipients Market Size was Estimated at USD 1239.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.30% from 2025 to 2035
• The Asia Pacific Pharmaceutical Excipients Market Size is Expected to Reach USD 2980.5 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the Asia Pacific Pharmaceutical Excipients Market Size is Anticipated to Reach USD 2980.5 Million by 2035, Growing at a CAGR of 8.30% from 2025 to 2035. The growing need for innovative drug delivery systems is driving the pharmaceutical excipients market in the Asia Pacific region.  

Market Overview

The Asia Pacific pharmaceutical excipients market involves the global trade of inactive substances used in drug formulations to enhance stability, bioavailability, and patient acceptability of active pharmaceutical ingredients (APIs). Pharmaceutical excipients are everything in the formulation other than the active pharmaceutical ingredient. They are formulated alongside the API of a medication, used to enhance the active ingredient’s therapeutic properties, facilitating drug absorption, reducing viscosity, enhancing solubility, and improving long-term stabilization. Factors, including rising emphasis on patient-centric drug formulation, demand for generic drugs, and increased R&D investments for developing novel excipients, are contributing to the market growth of pharmaceutical excipients. The increasing need for functional/multifunctional pharmaceutical excipients formed by combining two or more individual excipients, producing a synergistic excipient with superior functionality, is contributing to provide lucrative market growth opportunities.

Report Coverage

This research report categorizes the market for the Asia Pacific pharmaceutical excipients market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific pharmaceutical excipients market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific pharmaceutical excipients market.

Driving Factors

The increasing demand for generic medications and the increasing number of approved generic drugs are driving the demand for pharmaceutical excipients, thereby propelling the market demand. The increasing multifunctional excipients, with the driving need for a modern formulation approach, are contributing to driving the market growth. Innovative drug delivery systems leveraging advanced pharmaceutical excipients for enhancing drug efficacy and overcoming the limitations of conventional formulations are promoting the market growth.

Restraining Factors

The increased investment, development costs, and stringent regulatory standards are challenging the pharmaceutical excipients market. Further, the escalating geopolitical tensions are negatively impacting the market growth.

Market Segmentation

The Asia Pacific pharmaceutical excipients market share is classified into product and functionality.

• The organic chemicals segment held the dominant revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific pharmaceutical excipients market is segmented by product into organic chemicals, inorganic chemicals, and other products. Among these, the organic chemicals segment held the dominant revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment includes oleochemicals, carbohydrates, petrochemicals, proteins, and others, derived from natural origins. Pharmaceutical companies' growing focus on biodegradable and environmentally sustainable products is contributing to driving the market growth.

• The binder segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific pharmaceutical excipients market is segmented by functionality into binder, suspension & viscosity agents, glidants, and others. Among these, the binder segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Binders play an important role in the tableting process of pharmaceuticals, improving the cohesion and plasticity of the powder mixture. The role of binder for providing the desired shape to capsules or tablets is driving the market growth of pharmaceutical excipients.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific pharmaceutical excipients market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Ashland Inc.
• BASF SE
• Evonik Industries AG
• Roquette Frères
• Archer Daniels Midland Company
• JRS PHARMA GmbH & Co. KG
• MEGGLE GmbH & Co KG
• The Dow Chemical Co.
• The Lubrizol Corp
• Others

Recent Developments:

• In September 2022, DFE Pharma, a pharmaceutical and nutraceutical excipient solutions firmed, opened its new ‘Closer to the Formulator’ (C2F), a Centre of Excellence (CoE), at Genome Valley in Hyderabad.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Pharmaceutical Excipients Market based on the below-mentioned segments:

Asia Pacific Pharmaceutical Excipients Market, By Product

• Organic Chemicals
• Inorganic Chemicals
• Other Products

Asia Pacific Pharmaceutical Excipients Market, By Functionality

• Binder
• Suspension & Viscosity Agents
• Glidants
• Others